Even amid soaring COVID-19 cases in India, the world’s largest religious festival has brought massive crowds gathered “cheek by jowl” on the banks of the river Ganges this week,

In Mexico, COVID-19 vaccines are finally bringing a measure hope to a disappointing COVID-19 response (that has included disinfecting sidewalks), says Angélica López Hernández, a Mexico City-based consultant for the World Bank and the Inter-American Development Bank.

A speedy vaccine rollout is Bangladesh’s shining victory during the pandemic, but there aren’t enough takers for the shots, says Taufique Joarder, MBBS, DrPH, MPH, executive director of the Public Health Foundation, Bangladesh. Even as the country negotiated quick access to…

Ravaged by new surges, Brazil is now the pandemic’s epicenter as daily deaths top 3,000 and the health system is collapsing,

Overlooked during the global fixation on vaccinations: oral antivirals pills.   A pill-based “Tamiflu approach” would be easier than current therapies like monoclonal antibodies and convalescent plasma that need intravenous infusions.

A year ago, almost no one wore masks or stayed 6 feet apart from others. Some of these behaviors have become social norms at light speed—something those of us who have made social and behavior change communication our life’s work rarely see. Getting a vaccine needs to…

Peru’s problem in the global scramble for vaccines: It’s too rich for free COVAX doses but too poor to deploy the kind of programs its wealthier neighbors are rolling out.     

Vaccine teams are braving snow and sleet to get COVID-19 vaccines into arms—literally.   Carrying doses on a deadline, a vaccination team found themselves stuck in a massive snowstorm traffic jam outside Grants Pass, Oregon this week.  With vaccines due to expire within…

Deploying new vaccines has always been a messy business of logistical hurdles, ethical questions, and amazing feats.   Take the first-ever vaccine campaign, Spain’s 19th century effort to stamp out smallpox in its far flung colonies.

One Friday last month, I posted a map on Twitter. It drew immediate global attention, was seen by 8 million people, and has provoked strong responses and anger—and hopefully some soul-searching among those in governments and pharmaceutical companies.